The reported transaction involved 17,449 shares valued at ~$3.4 million at the transaction price of $196.31 per share. The disposition represented 14% of the insider's direct equity holdings, includin
According to a Form 4 filing, a Darden executive sold 2,226 shares for about $463,386 based on the July 29, 2026 weighted average execution price. Still, she retains 4,165 directly held shares and add
The transaction involved the sale of 4,373 shares at $210.42 per share on July 29, 2026, for a total value of about $920,200. King maintains a residual equity position of 742 directly held shares and
The disposition involved 8,478 shares valued at $1.8 million based on a weighted average price of $210.00 per share on July 29, 2026. The transaction reduced the CFO's direct equity holdings by 50% in
According to a Form 4 filing, Darden's CEO sold 39,134 shares on July 28, 2026, at a weighted average price of $209.06, totaling a transaction value of about $8.2 million. The transaction was executed
Dai ichi Life Insurance Company Ltd increased its position in shares of Darden Restaurants, Inc. (NYSE: DRI) by 66.7% in the first quarter, according to its most recent Form 13F filing with the Securi
Bank of Nova Scotia lessened its holdings in shares of Darden Restaurants, Inc. (NYSE: DRI) by 36.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange
Darden Restaurants earns a reiterated buy rating as LongHorn's growth reduces reliance on Olive Garden and diversifies earnings. Olive Garden's lighter-portions menu boosts visit frequency, supporting
This year, as the market is preoccupied with how the Iran war is propping up the energy sector and how the memory chip shortage has been driving the AI rally, there has been little focus on consumer d
California Public Employees Retirement System lessened its stake in shares of Darden Restaurants, Inc. (NYSE: DRI) by 13.6% in the first quarter, according to its most recent filing with the Securitie
First peer-reviewed publication of chemotherapy-resistant gamma-delta T cells (DeltEx Drug Resistant Immunotherapy or DRI) clinical results in newly diagnosed glioblastoma Repeat-dose patients achieve
DRI enters fiscal 2027 with growth from LongHorn, digital initiatives and new restaurants, while inflation and cautious spending test margins.
Darden combines earnings growth, cash returns and a lower valuation multiple, but estimate cuts and inflation keep investors weighing the stock's outlook.
DRI is balancing digital growth, brand diversification and value-focused pricing as inflation and consumer spending trends shape its margin outlook.

Dividend Announcements: June 20-26, 2026

03:46pm, Wednesday, 01'st Jul 2026
In this article series, I summarize dividend announcements of the past week. Thirteen companies in my database (including 7 banks) announced dividend increases. JPMorgan Chase stands out with a 10% di
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE